Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C. - Wikidata - wikimedia - TriplyDB

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.

http://www.wikidata.org/entity/Q34127370

about

Vitamin D supplementation for chronic liver diseases in adults Classical and emerging roles of vitamin D in hepatitis C virus infection Vitamin D and the anti-viral state Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients Vitamin D and chronic hepatitis C: effects on success rate and prevention of side effects associated with pegylated interferon-α and ribavirin Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review Association between vitamin D and hepatitis C virus infection: a meta-analysis Vitamin D deficiency: implications for acute care in the elderly and in patients with chronic illness.An update on the management of hepatitis C: consensus guidelines from the Canadian Association for the Study of the Liver.Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: A randomised double-blinded, placebo-control trial Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes.Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C.Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.Review article: the extra-skeletal effects of vitamin D in chronic hepatitis C infection.Vitamin D deficiency in chronic liver disease.1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial.Vitamin D status and viral response to therapy in hepatitis C infected children.Effect of vitamin D therapy on interleukin-6, visfatin, and hyaluronic acid levels in chronic hepatitis C Egyptian patients Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis.Antimicrobial implications of vitamin D.Influencing factors on serum 25-hydroxyvitamin D3 levels in Japanese chronic hepatitis C patients Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients.Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials.Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression Serum Adiponectin, Vitamin D, and Alpha-Fetoprotein in Children with Chronic Hepatitis C: Can They Predict Treatment Response?Theoretical basis of a beneficial role for vitamin D in viral hepatitis.Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response.Raloxifene inhibits hepatitis C virus infection and replication.In HIV/hepatitis C virus co-infected patients, higher 25-hydroxyvitamin D concentrations were not related to hepatitis C virus treatment responses but were associated with ritonavir use.The association between serological and dietary vitamin D levels and hepatitis C-related liver disease risk differs in African American and white males Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.Vitamin D deficiency and its relation to bone mineral density and liver fibrosis in HIV-HCV coinfection Adjudication of the alleged role of vitamin d in the antimicrobial pathway.Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study.Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine.Will vitamin d supplementation have a role in the treatment of patients with chronic hepatitis C?Vitamin D status of human immunodeficiency virus-positive patients with advanced liver disease enrolled in the solid organ transplantation in HIV: multi-site study.Could vitamin d supplementation benefit patients with chronic liver disease?The acyclic retinoid Peretinoin inhibits hepatitis C virus replication and infectious virus release in vitro.25-OH vitamin D level has no impact on the efficacy of antiviral therapy in naïve genotype 1 HCV-infected patients.

P2860

Q24187784-D183360F-836B-4978-8B05-E770DF0F76CC Q24561964-06837F80-E468-4FB7-A192-0B5B9D12B8B8 Q24613615-27267038-B64E-4285-A2DD-1D232E16A1C1 Q24624237-0AD121CB-7C50-4868-99BB-3CC0144EE9BA Q26784321-B470066D-A1DB-47D7-8890-FFAC429A03C7 Q26798289-8C4C86F0-5F6E-4850-BD2C-55C99FDEF6D6 Q26866361-677AE222-3E59-4F01-BC5A-302E93A11D3E Q30403062-5BA48F56-0502-480C-9AE0-DBA32748BF9A Q30453975-547DD4BE-0473-43D5-8F90-8C7CC592C6A3 Q33365130-DC1A4A58-E2F3-40EF-85DC-09909090E0D5 Q33958775-65BD25C1-F383-4AEB-AEAC-5CED63744489 Q34177249-33982F3A-C41D-4BA9-B988-EA70A940726B Q34203869-484D5CAA-78E1-4EDB-BDD9-30B1BFCCDCC9 Q34252987-1E854658-4083-4A91-BD0D-13B639054647 Q34728285-7518D29D-5E19-42BD-B53B-26D7C04187C3 Q34744383-23ADEFEF-EBFD-4DA8-AA21-463365003719 Q35012136-6B7FDDFD-6EC9-4A51-8900-6B8644DE5F47 Q35130052-9C32BD31-93C7-4936-A5B4-33531F15ABD2 Q35197174-6BFFF0D3-63E1-4869-87DD-0ECAC8655C8E Q35667399-4AD93F38-BF55-450C-90DB-669F26667A63 Q35749489-3F2B06EA-4A72-4148-9800-7164FD23D2E8 Q35776126-9685933B-7535-4D0D-9B3F-3A9533F49E4D Q36188710-B63568F3-69DB-4B81-A2F5-8C010084B6CF Q36295944-DD743476-24BD-48F2-88E1-6198534543CC Q36310310-0643EB24-803F-40CC-A83C-788F4B6E04FB Q36316676-A70F3392-77DB-486E-8F74-1611A664C800 Q36317075-A4540353-8D2A-4D6E-B035-38D6AA01A532 Q36811933-38C6CA14-6FA7-4AE0-9A71-99C601B153D0 Q37016495-2B29FB9F-5522-4A19-A3D0-6D2601045B4E Q37091418-407C80D5-54F9-4945-90BB-9250122E8F0A Q37170323-07175416-1959-4428-B01B-ADFB5A106181 Q37215057-896E0F13-5036-4583-816A-A26EBF9764BB Q37288171-A4A15544-DCB8-44AE-A3F1-AA34B08ECD25 Q37424371-7C65E3FD-7B57-47A0-9B27-8FB65A151511 Q37499899-D8D17F75-06AA-4139-A216-27DB38DEBF1D Q37613354-447E0E1C-3569-4078-AA48-ADBCCF20317E Q37625118-3D478FC0-7C74-4402-8BF9-0144F4AC8A22 Q37663928-BCBD8FC0-242D-4AE5-89B2-10B511834AA3 Q37702746-D2BC4A3F-B4C2-42A5-95A3-14298580B4ED Q37741812-995ACF5D-EBD1-49A9-9E16-088D71148F4D

P2860

Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C.

http://www.wikidata.org/entity/Q34127370

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@ast

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@en

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@nl

type

label

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@ast

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@en

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@nl

prefLabel

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@ast

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@en

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@nl

P1433

Q34127370-381BCE5D-CB0E-443D-9424-7591006951AB

P1476

Q34127370-69DCEAC0-99D7-4284-AEB4-283D7EC61D24

P2093

Q34127370-3C0E597A-CB48-498E-A49E-4B3AF6C8C345

Q34127370-474FA905-6457-405B-A19F-2CE630B857CC

Q34127370-6DA47230-5B6B-4673-B481-E575A66C11CC

Q34127370-83AD6C0C-D152-4601-8917-6337622C8C32

Q34127370-856C91DB-1BA9-48A4-950F-4984D465328F

Q34127370-867F1590-3CD6-4304-84AC-548618606D41

Q34127370-9091F587-1D87-4801-848C-89985A658B10

Q34127370-9BCDAC5C-4A1F-414B-BADE-C96C311395BC

Q34127370-A701ED98-7B51-49EC-8AB3-998E498732DA

Q34127370-AC9D011A-A1E5-40E4-94B3-656A4D4F1E3E

P2860

Q34127370-54B40D2E-C416-45BB-83C7-2CD6C97F48A8

P304

Q34127370-40BB54FD-27D9-417C-A54D-6F00D50B9024

P31

Q34127370-C82E094B-18AA-4D20-B499-97619548E393

P356

Q34127370-5FCDE0FF-602C-4943-BE6B-387211BE78FF

P433

Q34127370-CFAF1FFE-5B36-4FFD-A541-C7B9DD4E81E6

P478

Q34127370-BB6B0F29-5405-4F9D-A0A5-B107A2794CB9

P50

Q34127370-ED59089F-58D5-4D88-A046-058F267C1C7D

P577

Q34127370-D43EF299-9AA3-4FDE-8674-459DCBB3B0ED

P5875

Q34127370-EB13EC75-BD8D-4C9E-A01F-2153D4062104

P698

Q34127370-1C41F291-88E8-4AA7-9301-67845757CC1A

P921

Q34127370-0091e280-4b3a-dc1a-6b8d-adbc762c1064

Q34127370-45db7450-bc7c-4dc6-a566-2070d626ccf7

Q34127370-db69fcf6-4462-1af6-c2e4-6f23330db98d

P356

J.1432-2277.2010.01141.X

P1433

Transplant International

P1476

Vitamin D supplementation impr ...... ent for recurrent hepatitis C.

@en

P2093

Annarosa Cussigh

http://www.w3.org/2001/XMLSchema#string

Carlo Fabris

http://www.w3.org/2001/XMLSchema#string

Corrado Pipan

http://www.w3.org/2001/XMLSchema#string

Davide Bitetto

http://www.w3.org/2001/XMLSchema#string

Edmondo Falleti

http://www.w3.org/2001/XMLSchema#string

Elisa Fumolo

http://www.w3.org/2001/XMLSchema#string

Elisabetta Fontanini

http://www.w3.org/2001/XMLSchema#string

Ezio Fornasiere

http://www.w3.org/2001/XMLSchema#string

Pierluigi Toniutto

http://www.w3.org/2001/XMLSchema#string

Romina Martinella

http://www.w3.org/2001/XMLSchema#string

P2860

Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C.

P304

43-50

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1432-2277.2010.01141.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45281019

http://www.w3.org/2001/XMLSchema#string

P698

20649944

http://www.w3.org/2001/XMLSchema#string

P921